Company Filing History:
Years Active: 2021-2023
Title: Sarah Hogan: Innovator in Mesenchymal Stem Cell Research
Introduction
Sarah Hogan is a prominent inventor based in Raleigh, NC (US), known for her significant contributions to the field of mesenchymal stem cell (MSC) research. With a total of 2 patents, she has made strides in developing innovative methods for treating various medical conditions.
Latest Patents
Hogan's latest patents include "Enhancement of MSC immunomodulatory properties by treprostinil," which provides methods for treating or preventing vasculopathy. This patent outlines the administration of a composition comprising MSCs or components derived from MSCs to subjects in need. Additionally, her patent titled "Extracellular vesicles with enhanced potency" details methods for isolating potent extracellular vesicle or exosome populations from MSCs. This innovation aims to treat vasculopathy, including conditions such as pulmonary hypertension and mitochondrial dysfunction.
Career Highlights
Sarah Hogan is currently associated with United Therapeutics Corporation, where she continues to advance her research in stem cell therapies. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from various vascular diseases.
Collaborations
Hogan collaborates with esteemed colleagues, including Roger M Ilagan and John Cheadle, to further enhance the impact of her research in the field.
Conclusion
In summary, Sarah Hogan is a trailblazer in the realm of mesenchymal stem cell research, with her innovative patents paving the way for new therapeutic approaches. Her contributions are vital in addressing complex medical challenges, and her work continues to inspire advancements in the field.